HSC Spinout CxPM Joins StartUp Health’s Alzheimer’s Moonshot Community

"I embarked on this journey of creating a blood test for Alzheimer’s detection in primary care because of my own clinical and personal experiences," said UNT HSC's Dr. Sid O’Bryant, founder of Cx Precision Medicine. Now, by joining the Moonshot community, CxPM has gained "invaluable access to a network of investors, collaborators, and strategic partners" that could help drive its mission forward.

Cx Precision Medicine—a diagnostics company founded on research by Dr. Sid O’Bryant at UNT Health Science Center at Fort Worth—spun out from HSC to advance O’Bryant’s pioneering work on blood-based biomarkers for Alzheimer’s disease and other neurodegenerative conditions. The company recently gained higher visibility—and an even greater opportunity for impact—by being selected to join the prestigious StartUp Health’s Alzheimer’s Moonshot community.

Taking part in that “Moonshot” reinforces both CxPM and HSC’s place “at the forefront of the global effort to drive innovation in Alzheimer’s care and diagnostics,” HSC said in announcing the selection.

Research by CxPM Founder O’Bryant, who’s also a professor of family medicine at HSC and executive director of HSC’s Institute for Translational Research, is the driving force behind CxPM’s mission of improving early detection and treatment strategies for Alzheimer’s.

“I’m excited and humbled by the achievement of the CxPM team,” O’Bryant said in a statement. “I embarked on this journey of creating a blood test for Alzheimer’s detection in primary care because of my own clinical and personal experiences. I’m thrilled to see this soon come to fruition in clinics.”

Post-spinout, HSC has continued a collaborative relationship with CxPM via sponsored research activities, representation on the CxPM board, and “prosecution of patent applications in a strong, global intellectual property portfolio,” HSC said.

Impact of the Moonshot

New York-based StartUp Health Alzheimer’s Moonshot initiative is dedicated to advancing solutions to prevent, diagnose, and cure Alzheimer’s, a disease affecting more than 55 million people worldwide.

Joining the Alzheimer’s Moonshot community “marks a significant milestone” in CxPM’s journey, HSC said. The company is currently seeking to expand its operations and raise additional capital—goals that could be impacted positively by this new milestone. HSC said the Moonshot program offers “invaluable access to a network of investors, collaborators, and strategic partners.”

“We’re deeply honored to be a part of the Alzheimer’s Moonshot initiative,” CxPM CEO Danguole Altman said in a statement. “The collaboration between Cx Precision Medicine and HSC has been instrumental in bringing precision diagnostics to Alzheimer’s care. This will enable us to enhance our real-world impact on patients’ lives.”

As part of the Moonshot community, CxPM will now gain access to mentorship, global collaborations, and the opportunity to enhance its impact through partnerships with other innovators focused on Alzheimer’s care.

The achievement “highlights the role of academic research and innovation in addressing one of the world’s most challenging diseases,” HSC said, and positions CxPM “as a leader in precision diagnostics for Alzheimer’s disease.”

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.  

R E A D   N E X T

  • The project focuses on community-based intervention, and tasks HSC's SaferCare Texas clinical executives and School of Public Health staff with developing training education alongside HSC’s new College of Nursing and Fort Worth community-based organizations.

  • The DEC Network, organizers of Dallas Startup Week, are calling DSW24 "the second largest startup week in the USA" — and it kicks off this Sunday! The cornerstone event is gearing up to transform the DFW entrepreneurial landscape from August 11-15, promising five days of insights, connections, and opportunities. With the event just around the corner, we've crafted this ultimate guide—a blueprint for making the most of your time at DSW24. What is Dallas Startup Week? Dallas Startup Week, sponsored by Capital One, stands as the largest premiere event for small business owners and entrepreneurs in North Texas. This free,…

  • "Our mission is to help those who help others," says Pieces Technologies CEO Dr. Ruben Amarasingham. With $25M in growth funding, Dallas-based Pieces is gearing up to transform hospital care with AI that streamlines clinical workflows and eases the load on care teams.

  • A free, five-day celebration of entrepreneurship and innovation, Dallas Startup Week 2024 will be held August 11-15 in Frisco. Some 100 sessions and activations will be built around four compelling summits. The keynote speakers: a Grammy-winning musician and noted tech investor; an AI thought leader and best-selling author; "Shark Tank"-starring husband-and-wife "wine cocktail" brand co-founders; and a founding member of the legendary rap group NWA.

  • Mobility startups from coast to coast—including those focused on innovative ideas to transport people or goods—are invited to apply.  The unique accelerator program supports startups in the automotive ecosystem, ranging from AI-powered industry solutions and transportation infrastructure to dealer support and related services.